Podcast: Play in new window | Download
Podcast: Play in new window | Download
Podcast: Play in new window | Download
Sleep Part II
Let us pause here! So far we now know that humans at all ages will suffer from memory dysfunction and brain sewage cleanup problems leading to inflammation and damage long term. What ages are most at risk? They are likely mirrored by other physiologic events that are at risk based on age. Teenagers, infants and toddlers are rapidly growing creatures requiring more macro/micronutrients, water, and toxin avoidance for success. It is likely that sleep follows these same principles.
Going to a simple google scholar search for “sleep deprivation age risk” brings up countless articles on the effects of sleep deprivation in mothers and children on risk of obesity, diabetes, premature birth and much more.
….Plus more on gender and emotion as well as a recipe of the week.
Enjoy,
Dr. M
Podcast: Play in new window | Download
Kenneth R. Pelletier, MD, PhD is a Clinical Professor of Medicine, Department of Medicine; Department of Family and Community Medicine, and Department of Psychiatry at the University of California School of Medicine (UCSF) in San Francisco. He is Director of the Corporate Health Improvement Program (CHIP) which is a collaborative research program between CHIP and 15 of the Fortune 500 corporations including Ford, Oracle, Prudential, Apple, Dow, Lockheed Martin, Pepsico, IBM, American Airlines and NASA.
Dr. Pelletier served as Clinical Professor of Medicine at the University of Arizona School of Medicine and Stanford University School of Medicine. He was a Woodrow Wilson Fellow, studied at the CG Jung Institute in Zurich, Switzerland and has published over 300 professional journal articles in behavioral medicine, disease management, worksite interventions, alternative/integrative medicine, and epigenetics.
At the present time, Dr. Pelletier is a medical and business consultant to the US Department of Health and Human Services, the World Health Organization (WHO), the National Business Group on Health, the Federation of State Medical Boards, and major corporations including Cisco, IBM, American Airlines, Prudential, Dow, Disney, Ford, Mercer, Merck, Pepsico, Ford, Pfizer, Walgreens, NASA, Microsoft ENCARTA, Blue Cross/Blue Shield, United Healthcare, Health Net, the Pasteur Institute of Lille, the Alpha Group of Mexico, and the Singapore Ministry of Health.
Dr. Pelletier is the author of fifteen (15) major books, including the international bestseller Mind as Healer, Mind as Slayer and Change Your Genes – Change Your Life: Creating Optimal Health with the New Science of Epigenetics.
Today we enjoy the amazing viewpoint that Dr. Pelletier has for humanity. We have control over our destinies individually and collectively. This conversation is the culmination of years of incredible study.
Enjoy,
Dr. M
Podcast: Play in new window | Download
Podcast: Play in new window | Download
Klotho Part II
Last week we discussed Klotho as a protein that has pleotrophic effects in the body as it relates to cellular aging. This week let us focus specifically on the brain. What are the effects of klotho as it relates to cognition and function over time? Klotho has neuroprotective effects based on studies that show that better cognitive performance in translational models over time occur with the injections of klotho. Klotho is also shown to have neuroprotective effects if naturally elevated, i.e. individuals with host genetics that promote more klotho production over time without being taken or given.
The pivitol research occurred in 2015 in a mouse model of Alzheimers Disease (AD) where Dr. Dena Dubal and colleagues looked at two groups of intervention mice with and without higher levels of Klotho. and a literature review on micro plastics and screentime.
Enjoy,
Dr. M
Podcast: Play in new window | Download
Jeff Kessler, FACHE
Allergy Choices
This week I sit down with Jeff Kessler to discuss allergies and sublingual immune therapy.
Jeff Kessler is a business leader and a thought leader in the allergy therapy space. His relevant backstory goes back to 1999 when he had the fortunate opportunity to work on a project to select and implement an Electronic Medical Record system for the Allergy Associates of La Crosse (AAOL) clinic in La Crosse WI. Fortuitously for his daughter who at the time suffered profoundly with allergies, asthma and eczema, this opportunity presented a new course of therapy that would eventually be taken for the entire family leading to allergic disease modification. Enthralled with the therapy and company, Jeff dedicated his career in the healthcare industry from that point on to the allergy treatment approach that he witnessed change thousands of lives including his families. The growing AAOL organization became linked to Allergychoices, an education company dedicated to teaching healthcare providers around the U.S. on the protocol (La Crosse Method – LCM) that had been perfected since 1970. Jeff has served as President of Allergychoices since its formation and its services have grown to help providers deliver immunotherapy using the LCM to their patients directly at the primary care level. Bringing together AAOL, the most advanced allergy immunotherapy clinic in the U.S. and Allergychoices, capable of delivering the benefits of disease modifying allergy immunotherapy to anyone, anywhere, the distinctive competencies of these companies continue to help hundreds of thousands of allergy sufferers of all types, including foods.
Jeff earned a bachelors in science from the University of Wisconsin LaCrosse before he received his MBA in Strategic Planning from University of Minnesota’s Carlson School of Management in 1987.
Please enjoy my conversation with Jeff Kessler,
Dr. M
Podcast: Play in new window | Download